Full video transcriptClick to expand
Auto-generated transcript of @nikkiexplainsitall.again's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm gonna make some people mad, but glutathione,
- 0:01it doesn't burn.
- 0:02Glutathione is not spicy, it does not burn.
- 0:05When I do mine, it doesn't.
- 0:06And I'm gonna tell you how I do it.
- 0:08I hope this helps you.
- 0:09My dose is one full tool.
- 0:11I have to use special words.
- 0:13That's what I'm supposed to take, 100.
- 0:15So I break that up into two.
- 0:16So I do two different tools, each 50.
- 0:20I'll pull it, let it sit out to room temperature,
- 0:23so it's not cold.
- 0:24I do the tops of my glutes.
- 0:27Push slow.
- 0:30No burn.
- 0:30Sometimes it's maybe a little tender
- 0:33if I push on it after, but no burn.
- 0:36It's not spicy.
- 0:37So try that if you've been having issues with that.
- 0:40It doesn't burn, so.
Subcutaneous glutathione for perimenopause: what the evidence says
Quick answer
The creator is self-administering subcutaneous glutathione at what she describes as a 100-unit dose, split into two injections of 50 units each, at the upper gluteal region. Her technique recommendations, room temperature solution and slow injection speed, are consistent with standard subcutaneous injection guidance for reducing discomfort, though glutathione's acidic pH means formulation-specific irritation may persist regardless of technique. Subcutaneous glutathione is only legally available in the U.S. via prescription through a licensed compounding pharmacy, and users experiencing ongoing injection site reactions should consult their prescribing provider.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Subcutaneous glutathione for perimenopause: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Subcutaneous glutathione for perimenopause: what the evidence says should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Subcutaneous glutathione for perimenopause: what the evidence says" from Nikki talks G L P and O C D. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-administering subcutaneous glutathione at what she describes as a 100-unit dose, split into two injections of 50 units each, at the upper gluteal region.
The reason this review is not generic is the source wording and the canonical claim label "peptides controversial take i know everyone reacts differently but ho." In this clip, the useful excerpt is: "I'm gonna make some people mad, but glutathione, it doesn't burn." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Understanding weight gain at menopause (2012), Management of obesity in menopause (2024), and Management of menopause: a view towards prevention (2022), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is self-administering subcutaneous glutathione at what she describes as a 100-unit dose, split into two injections of 50 units each, at the upper gluteal region.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is self-administering subcutaneous glutathione at what she describes as a 100-unit dose, split into two injections of 50 units each, at the upper gluteal region. Her technique recommendations, room temperature solution and slow injection speed, are consistent with standard subcutaneous injection guidance for reducing discomfort, though glutathione's acidic pH means formulation-specific irritation may persist regardless of technique. Subcutaneous glutathione is only legally available in the U.S. via prescription through a licensed compounding pharmacy, and users experiencing ongoing injection site reactions should consult their prescribing provider.
- Cold solution temperature increases subcutaneous injection pain. Warming to room temperature before injection is supported by published injection technique research (Haynes et al., 2002, Pain).
- Slow plunger pressure reduces tissue distension during subcutaneous injection, a documented driver of the stinging or burning sensation many users report.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Cold solution temperature increases subcutaneous injection pain. Warming to room temperature before injection is supported by published injection technique research (Haynes et al., 2002, Pain).
- Slow plunger pressure reduces tissue distension during subcutaneous injection, a documented driver of the stinging or burning sensation many users report.
- Glutathione has an acidic pH that can contribute to local irritation independent of technique. If burning persists after adjusting method, the issue may be formulation-specific and worth discussing with your prescriber.
- Subcutaneous glutathione is not FDA-approved as a standalone injectable drug and is only legally available in the U.S. via prescription through a licensed 503A or 503B compounding pharmacy.
- Most clinical glutathione research uses intravenous or oral delivery routes. Subcutaneous bioavailability and efficacy data specifically are limited (Pizzorno, 2017, Integrative Medicine).
- Persistent injection site reactions including swelling, redness, or ongoing burning are not just technique problems. They should be reported to your prescribing provider, not solved through social media tips.
- Site rotation matters for long-term subcutaneous injection users. Repeated injections in the same location increase the risk of lipohypertrophy, which can affect both comfort and absorption over time.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @nikkiexplainsitall.again actually say?
She said glutathione injections are "not spicy" and "it doesn't burn" when done correctly. Her technique involves splitting a 100-unit dose into two 50-unit pulls, letting the solution reach room temperature before injecting, rotating to the upper glutes, and pushing the plunger slowly. She acknowledged occasional tenderness at the site afterward, but distinguished that from burning during injection.
This is a practical technique tip, not a therapeutic claim. She's not saying glutathione does anything specific for health outcomes. She's saying a common complaint among subcutaneous glutathione users, the burning sensation, can be reduced with simple injection habits. That's a narrower, more defensible claim than most peptide content on TikTok.
Does the science back this up?
Mostly, yes. The burning sensation from subcutaneous injections is well-documented and tied to several controllable variables, including solution temperature, injection speed, and site selection. The techniques she describes are consistent with what the clinical literature recommends.
Cold solutions cause more discomfort because they increase local tissue resistance and can trigger a brief vasospasm response. A 2002 study by Haynes et al. in Pain found that injection temperature significantly affected pain perception in subcutaneous tissue. Slower injection rates reduce pressure-mediated tissue distension, which is a known driver of stinging during subcutaneous delivery. The upper gluteal region has thicker subcutaneous fat padding compared to the abdomen or lateral thigh, which may dampen the sting response. None of this is controversial. These are standard principles taught in clinical injection technique training.
What's less clear is whether glutathione itself is more irritating than other compounds at comparable concentrations. Some users and compounding pharmacies note that glutathione's acidic pH can contribute to local irritation. Warming the solution could partially offset this, though no published trial has tested this specific workaround for glutathione specifically.
What did they get wrong (or right)?
She got the practical advice largely right. Letting a solution reach room temperature before injecting is a standard harm-reduction practice backed by injection technique literature. Slow plunger pressure is sound. Upper glute rotation is a reasonable site choice for reducing discomfort.
What's missing is any acknowledgment that individual variation in pain response is real and physiological, not just technique error. She says "I know eVerYonE rEaCTS diFfErEntLy" in the caption, which is a nod to this, but the video's tone is closer to "you're probably doing it wrong" than "here's one thing that worked for me." That framing matters. Some users experience burning from glutathione due to the compound's pH profile or the specific excipients in their compounded formulation, and no injection technique fully eliminates that.
She also never addresses whether she is using a prescribed formulation from a licensed compounding pharmacy, which is the only legal route for subcutaneous glutathione in the United States. That context gap is worth noting, even if it's not the video's focus.
What should you actually know?
Subcutaneous glutathione is not FDA-approved as a standalone injectable drug. It is available through licensed compounding pharmacies under a valid prescription, and formulation quality, including pH, concentration, and excipient choices, varies between compounders. That variation can directly affect injection comfort regardless of how good your technique is.
Glutathione is an endogenous antioxidant tripeptide. The research on subcutaneous glutathione supplementation is limited. Most published glutathione studies use intravenous delivery, oral forms, or nebulized routes. A 2017 review by Pizzorno in Integrative Medicine summarized glutathione's biological roles but noted that subcutaneous bioavailability data specifically remains thin. Claims about what subcutaneous glutathione does for perimenopausal women, immune function, skin, or energy are not well-supported by clinical trial data at this time.
If you are using subcutaneous glutathione and experiencing consistent burning, the technique tips in this video are worth trying. But if burning persists after adjusting temperature and injection speed, that may be a formulation issue worth raising with your prescribing provider, not just a technique problem you can solve on TikTok.
- Always confirm your glutathione is sourced from a licensed 503A or 503B compounding pharmacy.
- Injection site rotation reduces cumulative tissue trauma over time.
- Persistent injection site reactions should be reported to your prescriber, not troubleshot through social media.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Nikki talks G L P and O C D · TikTok creator
10.9K views on this video
controversial take? I know eVerYonE rEaCTS diFfErEntLy but honestly I think this helps! I am loving gluta so far! I take dose 3 tomorrow! #glutathionerecommendation #glutathionesubcutaneous #womenover40 #millennialmom #perimenopausal
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about cold solution temperature increases subcutaneous injection pain. warming to room?
Cold solution temperature increases subcutaneous injection pain. Warming to room temperature before injection is supported by published injection technique research (Haynes et al., 2002, Pain).
What does the video say about slow plunger pressure reduces tissue distension during subcutaneous injection, a?
Slow plunger pressure reduces tissue distension during subcutaneous injection, a documented driver of the stinging or burning sensation many users report.
What does the video say about glutathione has an acidic ph?
Glutathione has an acidic pH that can contribute to local irritation independent of technique. If burning persists after adjusting method, the issue may be formulation-specific and worth discussing with your prescriber.
What does the video say about subcutaneous glutathione?
Subcutaneous glutathione is not FDA-approved as a standalone injectable drug and is only legally available in the U.S. via prescription through a licensed 503A or 503B compounding pharmacy.
What does the video say about most clinical glutathione research uses intravenous?
Most clinical glutathione research uses intravenous or oral delivery routes. Subcutaneous bioavailability and efficacy data specifically are limited (Pizzorno, 2017, Integrative Medicine).
What does the video say about persistent injection site reactions including swelling, redness,?
Persistent injection site reactions including swelling, redness, or ongoing burning are not just technique problems. They should be reported to your prescribing provider, not solved through social media tips.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Nikki talks G L P and O C D, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.